This statistic depicts the pharmaceutical company ranking based on general access to medicine management in developing countries as of 2022, according to the Access to Medicine Index 2022. In that year, the company with the highest score in this category was Pfizer, with a total indicator score of 4.57.
Pharmaceutical company ranking based on governance of access in developing countries as of 2022
The Access to Medicine Index is an independent
initiative that ranks the world’s
20 largest companies according to their
efforts to make their products more available,
affordable and accessible in developing
countries, highlighting policy and
practice that either facilitate or hinder
access to medicine.
The Index uses a framework that evaluates
company activities in seven areas of activity,
or technical areas, considered to be key to
enhancing access to medicine in developing
countries, and across four important aspects
of action, or strategic pillars.
A score of zero means lowest and five signifies highest indicator score among the company set.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Access to Medicine Index. (November 15, 2022). Pharmaceutical company ranking based on governance of access in developing countries as of 2022 [Graph]. In Statista. Retrieved October 06, 2024, from https://www.statista.com/statistics/250428/global-pharma-company-ranking-by-access-governance/
Access to Medicine Index. "Pharmaceutical company ranking based on governance of access in developing countries as of 2022." Chart. November 15, 2022. Statista. Accessed October 06, 2024. https://www.statista.com/statistics/250428/global-pharma-company-ranking-by-access-governance/
Access to Medicine Index. (2022). Pharmaceutical company ranking based on governance of access in developing countries as of 2022. Statista. Statista Inc.. Accessed: October 06, 2024. https://www.statista.com/statistics/250428/global-pharma-company-ranking-by-access-governance/
Access to Medicine Index. "Pharmaceutical Company Ranking Based on Governance of Access in Developing Countries as of 2022." Statista, Statista Inc., 15 Nov 2022, https://www.statista.com/statistics/250428/global-pharma-company-ranking-by-access-governance/
Access to Medicine Index, Pharmaceutical company ranking based on governance of access in developing countries as of 2022 Statista, https://www.statista.com/statistics/250428/global-pharma-company-ranking-by-access-governance/ (last visited October 06, 2024)
Pharmaceutical company ranking based on governance of access in developing countries as of 2022 [Graph], Access to Medicine Index, November 15, 2022. [Online]. Available: https://www.statista.com/statistics/250428/global-pharma-company-ranking-by-access-governance/